ProRelix Research vs SMO India Clinical Research Pvt Ltd

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/prorelixresearch/smo-india

Category	ProRelix Research	SMO India Clinical Research Pvt Ltd
Listed site	cro	cro
Summary	ProRelix Research supports Phase 1–4 clinical trials across pharmaceutical, biotechnology, and medical device sectors, offering clinical trial project management, data management, and medical writing services in compliance with ICH and GCP principles across the US, India, Europe, and Australia.	CDSCO-registered CRO with 25+ years of clinical trial experience across Phase I–IV studies in India. Specializes in site management, clinical operations, and regulatory affairs across diverse therapeutic areas.
Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Data Management & eClinical Medical Writing Pharmacovigilance & Drug Safety Regulatory Affairs	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Regulatory Affairs
Modalities	Data not yet provided.	Data not yet provided.
Indications	Data not yet provided.	Data not yet provided.
Locations	United States, US, United States India, India, India Europe, Europe, Europe Australia, Australia, Australia	Headquarters, Bangalore, India
Certifications	Data not yet provided.	CDSCO · Identifier: CDSCO-registered
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.